Spondyloarthritis & psoriatic arthritis
Development of a web-based decision aid for initiating biological or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in axial spondyloarthritis
Authors' conclusion
We developed an evidence-based decision aid to support axSpA patients who face a treatment decision to initiate or switch a b/tsDMARD and introduced this in clinical practice.
Study context
- Population
- Patients with axial spondyloarthritis (axSpA) facing a decision to initiate or switch a b/tsDMARD
- Outcome
- Components of the decision aid
Methodological detailsiterative process, literature evidence, needs assessment interviews, stakeholder usability testing, Input from SpA working group of the Dutch Society for Rheumatology and Dutch Arthritis Society patient-information professionals; pilot tested among stakeholders for usability, ease of use and feasibility
- Iterative process
- Literature evidence
- Needs assessment interviews
- Stakeholder usability testing
- Input from SpA working group of the Dutch Society for Rheumatology and Dutch Arthritis Society patient-information professionals; pilot tested among stakeholders for usability, ease of use and feasibility
Main finding
As reported in the abstract
- Consultation support instructions in the context of disease control and treatment needs
- Overview of available treatment options for axSpA
- Detailed information on b/tsDMARDs and an interactive option grid to compare characteristics
- Final check supporting patients to deliberate on the decision to initiate or switch a b/tsDMARD
Further findings
Implementation in clinical practice
- Introduced by rheumatologists in several Dutch rheumatology settings; posted by the Dutch Arthritis Society on its website, social media and monthly newsletter
Original publication
Development of a web-based decision aid for initiating biological or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in axial spondyloarthritis. RMD Open. Published 1 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →